Dr Shigeki Iwase – Neurodevelopmental Disorders Arising from Histone Methylation Malfunctions

Mar 10, 2021 | Biology, Health and Medicine, Psychology and Neuroscience

Neurodevelopmental disorders range from those on the relatively common autism spectrum to much rarer disorders such as KDM5C-disorder and Weidemann-Steiner Syndrome. Exciting advancements in human genetics have shown that histones – the proteins our DNA wraps around – play a vital role in healthy brain development. Dr Shigeki Iwase from the University of Michigan studies how mutations in the enzymes that regulate histone structure and function can cause cognitive disorders. His work has led to important new discoveries, including how counterpart enzymes can be utilised for therapies.

Histones Condense the Genome

If you stretched out all the DNA contained in just one of your cells, it would create a thread around two metres long. However, safely within the nucleus of your cells, your DNA is coiled up tightly into the recognisable X shape of the chromosomes. To keep genetic material condensed and stable, it wraps around proteins called histones approximately 1.7 times. These proteins are found in groups of eight; when DNA has wrapped round one of these groups, it is known as a nucleosome. Many nucleosomes in repeating subunits create chromatin. As a result of all this wrapping and condensing, your genetic material in one cell, in the form of chromatin, is only around nine centimetres long.

The group of eight histones has a specific configuration and is made up of five variations of the protein – H1, H2A, H2B, H3 and H4. Because each histone protein is positively charged, they each bind strongly to DNA strands, which are negatively charged, thanks to the phosphate group in their backbone.

Histones

Modifying Histones for Cell Regulation

Histones also have an important role in regulating gene expression, which means controlling when and which parts of the genome are permitted to be transformed into proteins. When necessary, the proteins go through a process called covalent post-translational modification which alters the structure of chromatin, therefore impacting gene expression. Examples of post-translational modifications include phosphorylation, acetylation, ubiquitylation and methylation, all of which involve attaching a new molecule, compound or protein to the histone tail.

During methylation, enzymes called histone methylases attach one, two or three methyl groups to amino acids on the H3 and H4 proteins. It is therefore called mono-, di- or trimethylation, accordingly. These methyl groups are added to a lysine amino acid, which is abbreviated to ‘K’ or an arginine amino acid, abbreviated to ‘R’. Depending on how many methyl groups are attached and to which amino acid, the resulting nucleosome structure can be weakened. If the attractions between the DNA strand and the histone are diminished, the DNA will start to uncoil from the nucleosome which makes it much easier for RNA polymerases (transcription enzymes) to join on and begin the process of transcription. In this way, histone methylation can turn genes ‘on’. On the other hand, methylation of a lysine at the 9th position on H3 is a transcriptional silencing signal, and that gene will be turned ‘off’ for the time being.

The important enzymes which add on histone methylation are known as writer enzymes and their counterparts are eraser enzymes, which remove them. As with any other enzyme in our bodies, enzymes are proteins coded for by our genetics and are, therefore, subject to mutations that can alter our physiology. Studying this phenomenon, and how it may lead to intellectual disabilities and autism spectrum disorders, is Dr Shigeki Iwase from the University of Michigan in Ann Arbor. His research into how histone methylases and demethylases are vital for cognitive function has uncovered fascinating new information in his field.

Discovering a Gene Connected to X-linked Diseases

As the world of genetics research broadens and the knowledge of our inner workings deepens, scientists have realised that the histones within our nuclei can play an important role in brain development. A well-known modification to histones is the methylation of lysine 4 on H3 (H3K4me), which promotes transcription.

Initial work by Dr Iwase and his team led to the discovery of a new gene labelled KDM5C. This gene codes for a H3K4me2/3 demethylase, which is an enzyme that removes methyl groups from H3K4 when it is already di- or tri-methylated. Removing the methyl groups that would promote transcription means that this enzyme is a transcriptional repressor – it prevents transcription. The team found that when KDM5C is mutated in humans, it leads to a disorder called mental retardation, X-linked, syndromic, Claes-Jensen type. This condition is characterised by significantly diminished intellectual functioning, seizures, aggression and reduced height, all presenting during brain development.

Now called X-linked intellectual disabilities (instead of X-linked mental retardation), this family of disorders is inherited recessively through the female X chromosome. Because females have two X chromosomes, they can either inherit two mutated alleles (versions of the gene) and therefore express the disorder, or inherit one mutated allele and become just carriers of the disease. If only one of their X chromosomes carries the mutation, the ‘healthy’ one usually nullifies the diseased one. However, males hold only one X chromosome inherited from their mother and if they receive a mutated gene from her, will present with the X-linked disease. As a result, X-linked recessive diseases are more commonly found in males.

‘… the yin-yang action of writer-eraser enzymes can be targeted to ameliorate neurodevelopmental disorders.’

Mice and Humans with the Same Genetic Mutation Show the Same Symptoms

Building on this research, Dr Iwase investigated how mutations in KDM5C would affect mice and whether the consequences were comparable to humans with KDM5C mutations. The team knocked out certain sections within this gene (exons 11 and 12) to make it ineffective. Subsequently, the mice exhibited a smaller body size and diminished body weight. Interestingly, in humans, around 60% of individuals who are known to have a KDM5C mutation have a shorter than average stature.

Mice containing the mutation were significantly more aggressive than their littermates without it, were much less social and showed some memory impairment. All of these traits are found in many individuals with autism who hold KDM5C mutations and in those with X-linked intellectual disabilities.

Dr Iwase also found various neuropathway abnormalities in KDM5C knockout mice. Dendritic arborisation, or dendritic branching, is an essential part of brain development whereby neurons branch out to form new synapses. This was shown to be distorted in the mice, as they exhibited shorter and thinner dendrites in their basolateral amygdala – a centre in the brain for perceiving and regulating emotion, fear and aggression.

Overall, this study demonstrated how important KDM5C is for regulating pathways that lead to the normal development and function of neuronal circuitries. All of the data gathered from this experiment strongly suggest that mutations to KDM5C cause X-linked intellectual diseases because the loss of its function leads to gene expression that presents as clinical disease. The team believes that this is not just the case in mice but humans as well, as the cognitive deficits and behaviour patterns are so alike.

‘The Yin-yang Action of Writer-eraser Enzymes’

More recently, Dr Iwase examined whether a faulty histone enzyme could be modulated by using a different, functioning one.

The methylation processes of H3K4 are regulated by thirteen different enzymes but their functions in the brain are largely unknown. Genetic mutations in nine enzymes have strong associations with neurodevelopmental disorders, which are also known as brain H3K4 methylopathies in this context. Clinical genetics studies have told us that these enzymes are important in brain development.

Theoretically, as methylation modifications carried out by these enzymes are reversible, it could be possible to correct any errors by modulating the writer and eraser enzymes associated with them. Dr Iwase again used the eraser KDM5C enzyme which removes methylation, as well as including the writer enzyme KMT2A, which adds it. If a person is ‘haploinsufficient’ for the KMT2A gene, it means that they do not produce enough of the protein for proper function. Weidemann-Steiner Syndrome presents as a result, which causes intellectual disability and speech delay, short stature, characteristic facial features and hypotonia (decreased muscle tone).

Both of these enzymes should be found at high levels across the brain during development so that they can interact to regulate methylation. In a series of experiments on mice, the team found some fascinating results. In KDM5C-deficient mice, inhibiting KMT2A ameliorated many of the usual cognitive defects. So, the mice who could not properly remove methylation from histones when necessary, were prevented from increasing methylation which would otherwise result in disease. Likewise, cognitive issues arising from KMT2A mutation were alleviated by KDM5C deletion. It appears that controlling one of these partner enzymes amends the dysfunctions of the other, leading Dr Iwase to conclude, ‘…the yin-yang action of writer-eraser enzymes can be targeted to ameliorate neurodevelopmental disorders.’

Dr Iwase has helped the scientific community deepen its understanding of how methylation of histones – and dysfunctions in the process –can impact cognitive health and function. Importantly, his findings have exciting implications for the use of writer-eraser enzymes as potential remedies for neurodevelopmental disorders in the future.

Reference
https://doi.org/10.33548/SCIENTIA643

Meet the researcher


Dr Shigeki Iwase

Department of Human Genetics
University of Michigan, Medical School
Ann Arbor, MI
USA

Dr Shigeki Iwase completed his Bachelor of Science at the University of Tsukuba in Japan, before achieving his PhD from the same university in 2006. He then completed his postdoctoral training at Harvard Medical School in Boston in 2012. Since then, he has received multiple awards and published numerous papers on his studies. Dr Iwase now serves as an Associate Professor in Human Genetics at the University of Michigan in Ann Arbor, where he also carries out his research. His work focusses on chromatin in our genetic material and its involvement in health and disease in the brain.

CONTACT

E: siwase@umich.edu

W: https://medicine.umich.edu/dept/human-genetics/shigeki-iwase-phd

Twitter: @Iwase_Lab

KEY COLLABORATORS

Natalie Tronson (University of Michigan)

Jun Xu (Washington State University)

Yang Shi (Harvard Medical School)

FUNDING

National Institute of Neurological Disease & Stroke

Basil O’Connor Starter Scholar Research Awards from March of Dimes Foundation

Farrehi Family Foundation

FURTHER READING

CN Vallianatos, B Raines, RS Porter, et al., Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation, Communications Biology, 2020, 3(1), 1–14, doi:10.1038/s42003-020-1001-6

S Iwase, E Brookes, S Agarwal, et al., A Mouse Model of X-linked Intellectual Disability Associated with Impaired Removal of Histone Methylation, Cell Reports, 2016, 14(5), 1000–1009, doi:10.1016/j.celrep.2015.12.091

S Iwase, F Lan, P Bayliss, et al., The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 Demethylases, Cell, 2007, 128(6), 1077–1088, doi:10.1016/j.cell.2007.02.017

Want to republish our articles?

 

We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more

Creative Commons Licence
(CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Subscribe now!


More articles you may like

Dr Michael Wangler – Using Genetics to Diagnose Rare Metabolic Diseases

Dr Michael Wangler – Using Genetics to Diagnose Rare Metabolic Diseases

Identifying the cause of an illness in a sick baby or child is not always easy, particularly if the disease is rare. Throughout his career, Dr Michael Wangler, at the Baylor College of Medicine and Jan and Dan Duncan Neurological Research Institute, has investigated rare childhood diseases. Combining his expertise in paediatrics and genetics, Dr Wangler utilises genomics, metabolomics and the humble fruit fly to identify the genes responsible for rare and undiagnosed diseases to improve both diagnosis and treatment.

Dr Stephen Kry – Improving the Quality and Accuracy of Radiotherapy Through Research

Dr Stephen Kry – Improving the Quality and Accuracy of Radiotherapy Through Research

Radiation therapy is an effective and widely used method of treating cancer, and as with any treatment, it is essential to get the right dose. However, Dr Stephen Kry from The University of Texas MD Anderson Cancer Center has found widespread errors in the systems that calculate the doses patients receive. Through his research, he has helped to identify where these errors occur, how common they are, and provide possible solutions. He hopes that his work will go on to improve the quality and efficacy of radiotherapy for many cancer patients.

Dr Peter Bretscher – A Substantiated Framework for the Prevention and Treatment of Immune System-Related Diseases

Dr Peter Bretscher – A Substantiated Framework for the Prevention and Treatment of Immune System-Related Diseases

Immunity is generated normally against invaders, such as viruses and cancer cells, but not against parts of the body to which the immune system belongs. In 1970, Dr Peter Bretscher and Dr Melvin Cohn proposed a theory to account for how this is achieved. Importantly, immune responses against invaders can take one of two main forms, and Dr Bretscher (currently at the University of Saskatchewan) also proposed an explanation for how the choice of immunity is made. These two proposals are supported by diverse findings. Here, we outline and justify these proposals and explain how they lead to strategies to prevent and treat diverse diseases.

Dr Lakshmi Mahadevan – Mental Health First Aid: Bridging the Gap between Rural Communities and Access to Care

Dr Lakshmi Mahadevan – Mental Health First Aid: Bridging the Gap between Rural Communities and Access to Care

In the USA, poor mental health and opioid addiction are prominent and widespread. With a lack of understanding and resources in many rural areas in Texas, many people facing mental health and addiction challenges do not know where to turn. Dr Lakshmi Mahadevan at Texas A&M AgriLife Extension Service is helping to train up rural communities in Mental Health First Aid (MFHA) so that they can provide better care for those in need.